Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genentech's Ocrevus Manufacturing Process Still A Work In Progress

Executive Summary

Genentech overcame objections from US FDA quality reviewers to win approval of Ocrevus for multiple sclerosis by adding release and stability testing and committing to resolving process control issues, while suspending plans to accelerate post-approval manufacturing changes.

Advertisement

Related Content

European Approval Recommendation Delayed Again For Roche’s Ocrevus
Ocrevus Delay As CHMP Continues Assessment?
Not Just Herceptin Biosimilar: Additional 12 Drugs Set For EU Marketing Approval After CHMP Nod
New Treatments For Psoriasis, Ovarian Cancer And MS Seeking CHMP Thumbs Up This Week
Drug Review Profiles: Behind The Scenes At US FDA
US FDA's Search For Meaning: Interpretation Of Regulatory Language Can Inspire Conflict In Drug Reviews
Hot Topics At WCBP: Accelerated PPQ, Multi-Attribute Methods, ID And Stability Testing, Surfactant Control
Ocrevus Launching Quickly Even After Manufacturing Worries Delayed US Approval
FDA Urges Early Communication of CMC Data Gaps for Breakthrough Therapies
Breakthroughs for Patients, CMC Regulatory Flexibility

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120861

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel